Skip to content

Clinical trials

Recruiting Ovarian Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Recruiting Country / region: United States Clear all

248 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20041
20061
20101
20121
20133
20141
20151
20171
20184
20195
202012
202120
202222
202329
202439
202556
202647

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting248

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center15
National Cancer Institute (NCI)10
AstraZeneca7
Dana-Farber Cancer Institute6
Eli Lilly and Company5
Daiichi Sankyo4
Mayo Clinic4
Memorial Sloan Kettering Cancer Center4
Merck Sharp & Dohme LLC4
Northwestern University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms248
Breast Neoplasms77
Endometrial Neoplasms74
Fallopian Tube Neoplasms47
Pancreatic Neoplasms42
Uterine Cervical Neoplasms42
Colorectal Neoplasms41
Stomach Neoplasms39
Carcinoma, Non-Small-Cell Lung35
Prostatic Neoplasms33

Trials

Showing 1 to 25 of 248. Each trial links to its page on Pharma Observatory.

148 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.